Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bevacizumab versus bevacizumab and macular grid photocoagulation for macular edema in eyes with non-ischemic branch retinal vein occlusion: results from a prospective randomized study.
Callizo J, Atili A, Striebe NA, Bemme S, Feltgen N, Hoerauf H, Bertelmann T. Callizo J, et al. Among authors: bertelmann t. Graefes Arch Clin Exp Ophthalmol. 2019 May;257(5):913-920. doi: 10.1007/s00417-018-04223-9. Epub 2019 Jan 4. Graefes Arch Clin Exp Ophthalmol. 2019. PMID: 30610424 Clinical Trial.
Comparison of ranibizumab versus dexamethasone for macular oedema following retinal vein occlusion: 1-year results of the COMRADE extension study.
Feltgen N, Hattenbach LO, Bertelmann T, Callizo J, Rehak M, Wolf A, Berk H, Eter N, Lang GE, Pielen A, Schmitz-Valckenberg S, Quiering C, Rose U, Hoerauf H; COMRADE Study Group. Feltgen N, et al. Among authors: bertelmann t. Acta Ophthalmol. 2018 Dec;96(8):e933-e941. doi: 10.1111/aos.13770. Epub 2018 May 31. Acta Ophthalmol. 2018. PMID: 29855153 Free article. Clinical Trial.
Efficacy and safety of a fixed bimonthly ranibizumab treatment regimen in eyes with neovascular age-related macular degeneration: results from the RABIMO trial.
Feltgen N, Bertelmann T, Bretag M, Pfeiffer S, Hilgers R, Callizo J, Goldammer L, Bemme S, Hoerauf H. Feltgen N, et al. Among authors: bertelmann t. Graefes Arch Clin Exp Ophthalmol. 2017 May;255(5):923-934. doi: 10.1007/s00417-017-3589-x. Epub 2017 Jan 19. Graefes Arch Clin Exp Ophthalmol. 2017. PMID: 28102456 Clinical Trial.
Clinical Efficacy and Safety of Ranibizumab Versus Dexamethasone for Central Retinal Vein Occlusion (COMRADE C): A European Label Study.
Hoerauf H, Feltgen N, Weiss C, Paulus EM, Schmitz-Valckenberg S, Pielen A, Puri P, Berk H, Eter N, Wiedemann P, Lang GE, Rehak M, Wolf A, Bertelmann T, Hattenbach LO; COMRADE-C Study Group. Hoerauf H, et al. Among authors: bertelmann t. Am J Ophthalmol. 2016 Sep;169:258-267. doi: 10.1016/j.ajo.2016.04.020. Epub 2016 May 7. Am J Ophthalmol. 2016. PMID: 27163237 Clinical Trial.
Head-to-head comparison of ranibizumab PRN versus single-dose dexamethasone for branch retinal vein occlusion (COMRADE-B).
Hattenbach LO, Feltgen N, Bertelmann T, Schmitz-Valckenberg S, Berk H, Eter N, Lang GE, Rehak M, Taylor SR, Wolf A, Weiss C, Paulus EM, Pielen A, Hoerauf H; COMRADE-B Study Group. Hattenbach LO, et al. Among authors: bertelmann t. Acta Ophthalmol. 2018 Feb;96(1):e10-e18. doi: 10.1111/aos.13381. Epub 2017 Mar 2. Acta Ophthalmol. 2018. PMID: 28251811 Free article. Clinical Trial.
Ranibizumab Pro Re nata versus Dexamethasone in the Management of Ischemic Retinal Vein Occlusion: Post-hoc Analysis from the COMRADE Trials.
Pielen A, Feltgen N, Hattenbach LO, Hoerauf H, Bertelmann T, Quiering C, Vögeler J, Priglinger S, Lang GE, Schmitz-Valckenberg S, Wolf A, Rehak M. Pielen A, et al. Among authors: bertelmann t. Curr Eye Res. 2020 May;45(5):604-614. doi: 10.1080/02713683.2019.1679839. Epub 2019 Oct 31. Curr Eye Res. 2020. PMID: 31665935 Clinical Trial.
Real-World Data: Ranibizumab Treatment For Retinal Vein Occlusion In The OCEAN Study.
Callizo J, Ziemssen F, Bertelmann T, Feltgen N, Vögeler J, Koch M, Eter N, Liakopoulos S, Schmitz-Valckenberg S, Spital G. Callizo J, et al. Among authors: bertelmann t. Clin Ophthalmol. 2019 Nov 7;13:2167-2179. doi: 10.2147/OPTH.S209253. eCollection 2019. Clin Ophthalmol. 2019. PMID: 31806930 Free PMC article.
64 results